Literature DB >> 11089296

Concordance on the recording of cancer in the Saskatchewan Cancer Agency Registry, hospital charts and death registrations.

N S Rawson1, D L Robson.   

Abstract

Accurate and complete registries are an important source of knowledge about cancer. The concordance of the recording of neoplasms in the Saskatchewan cancer registry with that in hospital charts and death registrations was evaluated for 368 patients. The agreement between registry and hospital charts or death registrations was excellent (kappa: 0.93; 95% confidence interval: 0.89, 0.97), with 91.3% of those with cancer having the same neoplasm recorded in their chart or death registration as in the registry. There was only one patient whose hospital chart indicated cancer who was not in the registry and one apparent major discrepancy relating to the cancer site, which was due to the recording of the primary site in the registry and a secondary in the hospital chart. Although based on a relatively small number of patients, these results suggest a high degree of consistency between cancer registry, hospital charts and death registrations in Saskatchewan.

Entities:  

Mesh:

Year:  2000        PMID: 11089296      PMCID: PMC6979827     

Source DB:  PubMed          Journal:  Can J Public Health        ISSN: 0008-4263


  24 in total

1.  Reliability of the recording of hysterectomy in the Saskatchewan health care system.

Authors:  L Edouard; N S Rawson
Journal:  Br J Obstet Gynaecol       Date:  1996-09

2.  Reliability of the recording of schizophrenia and depressive disorder in the Saskatchewan health care datafiles.

Authors:  N S Rawson; E Malcolm; C D'Arcy
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  1997-05       Impact factor: 4.328

3.  Scottish validation study of Cancer Registration data childhood leukaemia 1968-1981--I.

Authors:  S Glass; M Gray; O B Eden; I Hann
Journal:  Leuk Res       Date:  1987       Impact factor: 3.156

4.  Data quality in population-based cancer registration: an assessment of the Merseyside and Cheshire Cancer Registry.

Authors:  D J Seddon; E M Williams
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

5.  Why did treatment rates for colorectal cancer in south east England fall between 1982 and 1988? The effect of case ascertainment and registration bias.

Authors:  A M Pollock; R Benster; N Vickers
Journal:  J Public Health Med       Date:  1995-12

6.  Quality of cancer registry data: a comparison of data provided by clinicians with those of registration personnel.

Authors:  L J Schouten; J J Jager; P A van den Brandt
Journal:  Br J Cancer       Date:  1993-11       Impact factor: 7.640

7.  Assessing completeness of cancer registration in the north-western region of England by a method of independent comparison.

Authors:  U Nwene; A Smith
Journal:  Br J Cancer       Date:  1982-10       Impact factor: 7.640

8.  The reliability of Cancer Registry records.

Authors:  M C Gulliford; J Bell; H M Bourne; A Petruckevitch
Journal:  Br J Cancer       Date:  1993-04       Impact factor: 7.640

9.  Completeness of cancer registration in England and Wales: an assessment based on 2,145 patients with Hodgkin's disease independently registered by the British National Lymphoma Investigation.

Authors:  A J Swerdlow; A J Douglas; G Vaughan Hudson; B Vaughan Hudson
Journal:  Br J Cancer       Date:  1993-02       Impact factor: 7.640

10.  The impact on colorectal cancer survival of cases registered by 'death certificate only': implications for national survival rates.

Authors:  A M Pollock; N Vickers
Journal:  Br J Cancer       Date:  1994-12       Impact factor: 7.640

View more
  5 in total

Review 1.  Healthcare Databases for Drug Safety Research: Data Validity Assessment Remains Crucial.

Authors:  Nigel S B Rawson; Carl D'Arcy
Journal:  Drug Saf       Date:  2018-09       Impact factor: 5.606

2.  A population-based study of age inequalities in access to palliative care among cancer patients.

Authors:  Frederick I Burge; Beverley J Lawson; Grace M Johnston; Eva Grunfeld
Journal:  Med Care       Date:  2008-12       Impact factor: 2.983

3.  A population-based case-control study of Selective Serotonin Reuptake Inhibitors (SSRIs) and breast cancer: the impact of duration of use, cumulative dose and latency.

Authors:  J E Ashbury; L E Lévesque; P A Beck; K J Aronson
Journal:  BMC Med       Date:  2010-12-22       Impact factor: 8.775

4.  Quantifying data quality for clinical trials using electronic data capture.

Authors:  Meredith L Nahm; Carl F Pieper; Maureen M Cunningham
Journal:  PLoS One       Date:  2008-08-25       Impact factor: 3.240

5.  The effects of transdermal and oral oestrogen replacement therapy on colorectal cancer risk in postmenopausal women.

Authors:  I Csizmadi; J-P Collet; A Benedetti; J-F Boivin; J A Hanley
Journal:  Br J Cancer       Date:  2004-01-12       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.